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Summary
The mouse «1(II) collagen gene has been isolated and a
5' portion of the gene which has low homology to other
collagen genes was used to study the pattern of
expression during mouse embryogenesis. In situ hybrid-
ization studies show that in the mouse, like the chick,
«1(TI) collagen is expressed hi chondrogenic tissues hi
advance of chondrocyte differentiation. The gene is
expressed early in embryogenesis at 9.5 days both in the
cranial mesenchyme destined for the chondrocranium,
and the sclerotome of the somites, and at 12.5 days hi the
primordia of the hyoid and the laryngeal cartilage. Type
II collagen gene transcripts were found in all the
chondrogenic tissues of the axial and appendicular
skeleton until the onset of endochondral ossification.
Expression of al(TJ) collagen mRNA was also observed
hi non-chondrogenic tissues such as the notochord which
may be responsible for inducing chondrogenesis hi
somitic mesoderm, neural retina, the corneal and
conjunctiva! epithelia and sclera of the developing eye.
Expression in the tail tendon was late, at 16.5-18.5 days.
Transient expression was also found hi the heart at
9.5-12.5 days, the epidermis at 10.5-14.5 days, the
calvarial mesenchyme at 12.5-16.5 days, the inner ear
at 14.5 days and the fetal brain from 9.5-14.5 days.
Within the neural tube, al(Tf) collagen mRNA was
localized in the proliferative ventricular cells of the
forebrain and midbrain of 9.5- to 10.5-day embryos.
Subsequently, transcription of the al(II) collagen gene
was confined to restricted areas of the rhombencephalic
basal plate, the ventricular layer of the hindbrain and
the cervical spinal cord. These examples of expression of
the type II collagen gene in the developing nervous
system seem to suggest that active transcription of this
gene might be associated with early stages of neuroblast
differentiation. Type II collagen may therefore have
additional roles hi development unrelated to chondro-
genesis.
Key words: al(U) collagen gene, mouse embryo, in situ
hybridization, chondrogenesis, neurogenesis.
Introduction
Collagens are major structural proteins of the extra-
cellular matrix and the correct temporal and tissue-
specific expression of the collagen genes is crucial for
the proper development of form during morphogenesis
(Adamson, 1982; Reddi, 1984). The critical role of the
expression of some collagen genes in mammalian
development is illustrated by the perinatal lethality
caused by the intergration of a retro virus in the 5'
region of the mouse al(l) collagen gene (Schniecke et
al. 1983; Harbers et al. 1984).
In vertebrates, there are at least 13 types of collagens
made up of 25 genetically distinct a chains which are
expressed in various combinations and amounts in
different tissues (Miller and Gay, 1987; Vuorio and
deCrombrugghe, 1990). Type II collagen has been
classically recognized as the major collagenous com-
ponent of cartilage. Because type II collagen is
synthesized in mesenchymal cells in advance of overt
chondrogenesis (Kravis and Upholt, 1985; Kosher et al.
1986; von der Mark and von der Mark, 1977; Swalla et
al. 1988), it has been suggested that the expression of
the al(II) collagen gene may define and determine the
sites and timing of chondrogenesis (Thorogood et al.
1986).
Apart from chondrocytes and their precursor cells,
the presence of type II collagen has also been found by
biochemical and immunohistochemical staining
methods in non-chondrogenic tissues in avian embryos
(chick and quail). Such tissues include the notochord
(von der Mark et al. 1976), neural retina (Newsome et
al. 1976; Smith et al. 1976; Von der Mark et al. 1977;
Linsenmeyer and Little, 1978; Oettinger et al. 1985;
Thorogood et al. 1986), corneal epithelium (Linsen-
meyer et al. 1977; Hayashi et al. 1988; Fitch et al. 1988,
1989), vitreous body (Trelstad and Kang, 1974),
ventrolateral surface of the neural tube (Thorogood et
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al. 1986) and in the basement membrane of the otocyst,
surface ectoderm, gut endoderm, mesonephxic duct,
dorsal aorta and heart (Kosher and Solursh, 1989;
Mallein-Gerin, 1990). These recent findings of wide-
spread expression of the type II collagen gene in the
early avian embryo are strongly suggestive of a function
other than for chondrogenic development.
In contrast to the avian species, the temporal and
spatial pattern of expression of the al(II) collagen gene
has not been studied in the mammalian embryo. We
report here the isolation of the 5' first exon of the
mouse ad(II) collagen gene. DNA sequence compari-
sons between the mouse, rat and human al(II) collagen
genes show that the gene is highly conserved at both
nucleotide and amino acid levels. Antisense RNA
probes for mouse al(II) collagen mRNA were used to
determine, by in situ hybridization, whether the ol(II)
collagen gene in the developing mouse is expressed in
both chondrogenic and non-chondrogenic tissues. An
understanding of the normal expression of type II
collagen is also essential for the interpretation of future
studies on the phenotypic consequences of genetic
defects in the 0-1(11) collagen gene.
Materials and methods
Isolation of the mouse al (II) collagen gene
A mouse genomic library constructed in the cosmid vector,
Lorist2 (gift of P. Little, Imperial College, London), was
screened by hybridization methods described by Cross and
Little (1986), using as a probe, a 9.8kb EcoKl fragment from
the human ad(II) collagen gene (Cheah et al. 1985). Library
filters were washed in lxSSC, 0.1 % SDS at 65°C. From this
screening, strongly hybridising clones were isolated and
characterised. One clone was chosen for further study
because of its strong hybridization to the 5' and 3' ends of the
human al(II) collagen gene (Cheah, et al. 1991). An 850bp
Pstl-Sali DNA fragment which hybridised strongly to the 5'
first exon of the human gene was subcloned into Bluescript
KS~ (Stratagene, USA) and sequenced (Fig. 1). This
subclone, pEL107, and a shorter derivative, pELlll, contain-
ing the 600 bp Accl-Sall DNA fragment subcloned into
pGEM3 (Promega, USA) were used for in situ hybridization
studies.
DNA sequencing
The region covering the first exon of the mouse a-l(II)
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Smal Accl Sad Pstl
PEL107
100 bp
Fig. 1. Restriction enzyme map of DNA subclones used
for DNA sequencing, RNAase protection assays and in situ
hybridization. pELlll and pEL107 are overlapping
subclones containing the 5' first exon of the mouse ad(II)
collagen gene. The position of exon 1 is represented as a
black box. The portions of pEL107 sequenced and the
direction of DNA sequencing are shown by the arrows.
collagen gene was sequenced on both strands by the dideoxy
chain termination method (Sanger et al. 1977) on double-
stranded DNA using Sequenase 2.0 (United States Biochemi-
cal, USA) following the manufacturer's protocol. The
complete DNA fragment was sequenced using the
exonuclease/mungbean nuclease method of generating over-
lapping clones (Henikoff, 1987). Sequence comparison
analyses were performed using the UWGCG computer
programs of Devereux et al. (1984).
RNA isolation and RNAase protection assays
Total RNA was isolated from 16.5-day mouse fetuses using
the lithium chloride-urea method (Lovell-Badge, 1987).
pELlll was used to generate ^P-labelled antisense RNA
probes for RNAase protection assays using T7 RNA
polymerase as described by Melton et al. (1984). Hybridiz-
ation was in 80% formamide, 40mM Pipes pH6.7, 400mM
NaCl, lmM EDTA at 50°C for 18h. Non-hybridized RNA
was removed by digestion with RNAase A (lO^gml"1) and
RNAase Tl (0.5 /igmT1) for 15 min at 37°C and the protected
RNA fragments electrophoresed on 6 % polyacrylamide/8M
urea gels as described by Lovell-Badge (1987).
In situ hybridization
CBA/n mouse fetuses at 9.5 to 18.5 days p.c. (plug day=0.5
p.c.) were collected and processed for in situ hybridization as
described by Wilkinson et al. (1987). Single-stranded 35S-
labelled sense and antisense RNA probes were generated
from pEL107 using T3 and T7 RNA polymerase, respectively,
and from pELlll using SP6 and T7 RNA polymerase,
respectively. Antisense S-labelled RNA probes for mouse
0-1(1) collagen were generated from a subclone containing
exon 2 of the gene (gift of R. Lovell-Badge, National Institute
for Medical Research, London). LM-1 (Amersham) or K5
(Ilford) photographic emulsion was used for autoradiogTaphy.
Slides were developed in Phenisol (Ilford) and stained with
Harris haematoxylin and eosin or toluidine blue. Photographs
of sections were taken using Kodak Ektachrome ASA 50 film
on a Zeiss microscope with dark-field illumination alone or by
a combination of dark-field illumination followed by bright-
field microscopy with a red filter to produce superimposed
images.
Results
The 5' end of mouse al (II) collagen gene is highly
conserved
The DNA fragment encoding the 5' first exon of the
mouse ad (II) collagen gene was identified by strong
cross-hybridization to the equivalent region of the
human COL2A1 gene previously isolated (Cheah et al.
1985) and by nucleotide sequence analysis. DNA
sequencing of pEL107 showed that it contained the 5'
first exon of the ol(II) collagen gene, which codes for
the 5' untranslated region, the signal peptide and the
start of the amino-propeptide of the pro-ad (II) chain.
The size of the 5' first exon as determined by RNAase
protection (Fig. 2) is approximately 235 bp and is
therefore similar in size to the equivalent part of the rat
and human genes (240 bp) (Kohno et al. 1985; Nunez et
al. 1986). Comparison of the coding sequence of this
region of the mouse al(II) collagen gene with that of
the human and rat genes show homologies of 94 % and
95 %, respectively, at the nucleotide level and 93 % at
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helical and carboxy terminal portions (Dion and Myers,
1987; Ramirez et al. 1985). The absence of other lower
molecular weight protected RNA fragments in the
RNAase protection assays with 16.5 day fetuses suggest
that there were no other mRNA transcripts in the
mouse embryo with any significant homology to the
probe. Nucleotide comparisons of this portion of the
mouse a'l(II) collagen gene with available sequences of
other collagen genes [o-l(I), al(IV), o2(IV), o2(I)]
showed no homology (data not shown). This region of
the gene therefore provides a probe specific for ad (II)
collagen mRNA for this in situ hybridization study.
Similar RNAase protection results were obtained with
10.5-and 13.5-day fetuses, confirming the specificity of
t n e
 probe at earlier times of development (Cheah and
Lau, unpublished). The use of this same RNA probe for
in situ hybridization combined with RNAase treatment
of sections, post-hybridization, is equivalent to
RNAase protection assays, in situ, and also reduces the
possibility of generating artifactual positive signals.
Type II collagen mRNA expression in chondrogenic
Fig. 2. The 5' first exon of the mouse a-l(II) collagen tissues
gene. Autoradiogram showing RNA fragments from 16.5- Transcripts of the type II collagen gene were screened
day fetuses protected from RNAase digestion after for in tissues of fetuses at 8.5 to 18.5 days p.c. by in situ
hybridization to 32P-labelled antisense RNA transcripts hybridization with antisense R N A probes transcribed
synthesized from pELl l l . Samples were: lane 1: DNA from pEL107 and p E L l l l . Both probes produced
molecular weight markers; 2: 16.5-day mouse fetal RNA similar results
hybridised to antisense pELl l l ; 3: No RNA control; 4:
 A l o w , e v d o f hybridization was observed in the 8.5-
Intact antisense RNA transcript.
 d a y c o n c e p t u s o v e r t h e e x t raembryonic yolk sac (data
not shown). Significant hybridization was first detected
„ , . „ , . _ , „ „ „ , . „ , , _ in the sclerotome of the somites and the notochord in
Mouse GCGGTGAGCCATGATCCGCCTCGGGGCTCCCCAGTCGCTGGTGCTGCTGACG the trunk of 9.5-day embryos (Fig.-4A). Transcripts
Rat T — were not found in the dermamyotome, the newly
Human
 T A segmented somites and the presomitic mesoderm. A
* similar but stronger pattern of hybridization was found
^ 4 4. in the perinotochordal sclerotome (Fig. 4B), the pre-
L L I A A V L R C Q G Q D A vertebral and vertebral mass and in the paraxial
Mouse cTGCTCATCGccGCGGTccTACGGTGTCAGGGccAGGATGcccgtaagtcgc
 m esoderm (Fig. 4C,D,E) of the 10.5- to 12.5-day
r Q fetuses. Specific hybridization was also detected as early
Human G T T T tt
 a s 95 davs p.c. in the cranial mesenchyme associated
with the mid- and hindbrain. Progressively more type II
collagen mRNA was found in the cranial mesenchyme
Fig. 3. DNA and ammo acid sequence comparisons
 w t h e e m b r y o developed (Fig. 4D). Expression wasbetween exon 1 of the mouse, rat and human orl(n) observed in mesenchymal cells well before any overt
collagen genes. The sequence of part of the 5 untranslated , , . . . . . . ^ . ir
region, initiation codon, the signal peptide and the start of chondrogenesis could be detected. Other examples of
the NH2-propeptide are shown. Amino acid residues are in a n e a r l y expression of the o-l(II) collagen gene are the
the standard single-letter code and shown in italics and primordia of the hyoid and thyroid cartilages located at
bold type. Only base differences are shown, sequence the root of the tongue of the 12.5-day fetus (Fig. 4F).
identity is denoted by a dash. Intron sequences are in An early expression of ad(II) collagen mRNA was
lower case, exon sequences in upper case. The arrows therefore observed in mesenchymal cells well ahead of
denote the potential signal peptide cleavage sites.
 a n y o v e r t chondrogenesis which is normally first
Sequences for the rat and human arl(II) collagen genes are detected at 12.5-14 days p c. (Rugh, 1968). By 14.5 to
taken from Kohno et al. 1985, and Nunez et al. 1986
 l f i 5 d prominent expression of the ol( I I )
v y
' transcripts was found in all cartilaginous structures such
as the vertebral column, the chondrocranium
the amino acid level (Fig. 3). This exon is therefore (Fig. 4G,H), otic capsule, nasal septum, jaw, limb
highly conserved in the three mammals, especially cartilage, tracheal rings and ribs (Fig. 4H). In contrast,
between mouse and rat. hybridization with the probe for a4(I) collagen mRNA
Homologies of up to 60% exist between different showed a very different pattern of expression (Fig. 41).
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Type I collagen mRNA was not expressed in any
chondrogenic tissue but was found at high levels in the
skin, calvarium, fascial and peritoneal membranes
surrounding internal organs, ossified bones and the
perichondrium.
Expression of cd (II) collagen mRNA in non-
chondrogenic tissues
Type II collagen gene transcripts were confined not just
to cartilaginous tissues and their precursors. Expression
of al(II) collagen mRNA was also found in the calvarial
mesenchyme, the notochord, the heart, the epidermis,
the tail tendon and the fetal brain. Type II collagen
mRNA was detected in the ectomesenchyme beneath
the surface ectoderm in the 12.5- (Fig. 4D) to 14.5-day
fetus (Fig. 4G,H). The level of transcript was high up to
16.5 days p. c. by which time the mesenchymal cells had
differentiated to form osteoblasts of the calvarium
during intramembraneous ossification. The developing
calvarial bones were one of the few sites at which al(II)
and arl(I) collagen genes were co-expressed. This is in
contrast to the other bones of the skull which form
differently by endochondral ossification of a cartilagi-
nous anlage. The levels of expression of al(ll) collagen
mRNA in the developing calvaria was relatively lower
than in the cartilage and lower than the expression of
the arl(I) collagen gene.
The notochord of 9.5- to 12.5-day fetuses showed a
strongly positive hybridization with the type II collagen
RNA probes (Fig. 5A). In normal development, with
the exception of the primordia of the nucleus pulposus
of the intervertebral disc, most parts of the notochord
regress during the formation of the cartilaginous
vertebral body. There was a concomitant diminution of
the intensity of hybridization in the notochordal tissues
of the 14.5 and 16.5-day fetuses. The od(H) collagen
gene was transiently expressed in the epicardium and
the myocardium of the heart in 9.5 to 12.5-day fetuses
(Fig. 5B). Type II collagen mRNA was not detected in
the endocardium or the pericardium, and was absent at
later stages of cardiac development. However, type I
collagen mRNA was expressed in the pericardium
instead. Expression of al(II) collagen mRNA was also
detected transiently in the surface ectoderm at 10.5 to
14.5 days p.c. (Fig. 4C,E,H and 5A) but was absent by
16.5 days p.c. In contrast to the early expression in the
heart and surface ectoderm, type II collagen mRNA
was found much later in the tail tendon of the 16.5- to
18.5 day fetuses (Fig. 5C).
By far the most unexpected expression of the al(II)
collagen gene was that observed in the developing brain
of 9.5- to 14.5-day fetuses. Type II collagen mRNA was
first detected at low levels in the telencephalic
neuroepithelium at 9.5 days p.c. and became more
prominent from 11.5 days onwards. Type II collagen
mRNA was initially uniformly distributed in the
neuroepithelium of the fore- and midbrain vesicles but
was subsequently more localised in the tissue on the
floor of the mesencephalon at 12.5 days p.c. (Fig. 5D).
By 14.5 days p.c., a high level of transcripts was found
in the ventricular layer of the cerebral vesicles and the
Fig. 4. The localization of type H collagen mRNA in the
tissues of mouse fetuses by in situ hybridization.
Accumulation of transcripts are found in the following.
(A) The sclerotome of the differentiating somites (sc) and
the notochord (nd) of a 9.5-day embryo, (B) The
perinotochordal condensation of the sclerotome (sc) in the
caudal region of a 12.5-day fetus, (C) The pre-vertebrae
(pv) in the upper trunk region of a 12.5-day fetus but no
hybridization in the adjacent spinal ganglia (sg), (D) The
cranial mesenchyme (pm) ventral to the developing brain
vesicles, with a much stronger hybridization in the
mesenchyme adjacent to the hypophyseal pouch (rp) and
the otocyst (arrow) in a 10.5-day embryo, (E) The
chondrocytes in the developing centrum (en) of the
vertebrae of a 12.5-day fetus, (F) The mesenchymal cell
masses (arrowheads) found at the root of the tongue (tn)
which are destined to form the hyoid bone and the thyroid
cartilage and the periotic mesenchyme (om) of a 12.5-day
fetus, (G) The superfical mesenchyme (sm) over the
cerebral vesicles which is destined for the frontal bone and
part of the parietal bone and that of the supraoccipital
bone (sb) covering the rhombencephalon, cells in the
hippocampal cortex (arrows), the ventricular cell layer in
the cerebral vesicles (cv), the diencephalon (di), the
mesencephalon (me) and on the floor of the fourth
ventricles in the rhombencephalon (arrowhead). (H) and
(I) provide a comparison of the pattern of localization of
the transcripts of arl(II) and <*1(I) collagen genes on two
sagittal sections of 14.5-day fetuses. With the exception of
the calvaria and the differentiating epidermis, the
localization of the transcripts for the two collagen types
appears to be mutually exclusive, nt, neural tube; md,
mesenchyme for mandible; om, periotic mesenchyme; se,
surface ectoderm. Bar 100 fan except for G,H and I where
it represents lmm.
diencephalon (Fig. 4G, 5E). Type II collagen mRNA
was also detected in the neural retina, the corneal and
conjunctival epithelium and the sclera of the developing
eye (Fig. 5F). Cells in the hippocampal cortex (Fig. 4G)
and the thalamus showed a particularly strong hybridiz-
ation at this stage (Fig. 5E). In the midbrain and
hindbrain regions, the transcripts were more localised
in the ventricular layer of the basal plate. Expression
was strongest in two longitudinal bands of the basal
ventricular cells nearest to the floor plate (Fig. 5G). A
low level of transcript was also detected in the basal
plate ventricular layer of the medulla oblongata and the
cervical spinal cord (Fig. 5H), while none were found in
the mature tissue of the spinal cord or the spinal
ganglia. A much diminished level of expression was
observed in the ventricular and the intermediate cell
layers of the 16.5-day fetal brain. Type II collagen
mRNA was also detected in the epithelium of the otic
vesicles of the 9.5- and 10.5-day fetus (Fig. 51) and in
the differentiating otic epithelium of the inner ear
(Fig. 5J) of 14.5-day fetuses.
Among the non-chondrogenic tissues, the 0-1(1) and
a-l(II) collagen genes were co-expressed transiently in
the epidermis (at 10.5 days), and later in the calvaria
(14.5-16.5 days) and the tail tendon (at 16.5-18.5
days). However, no expression of type I collagen
mRNA was found in the brain at any stage of
4A
sc
nd
M.USJ

Type II collagen gene expression 949
Fig. 5. Localization of type II collagen mRNA by in situ
hybridization. (A) The notochord (nd) and the sclerotome
(sc) in the trunk of a 10.5-day embryo, (B) The
myocardium and epicardium of the ventricle (v) and atrium
(at) of the developing heart of the 10.5-day embryo same
as Fig. 4D, (C) The tendon (tn) in the tail of a 16.5-day
fetus, (D) The ventricular cell layer (vn) of the
diencephalon with a concentration of the transcript to the
floor of the brain vesicle and a much diminished level of
transcripts in the intermediate cell layer (im) of a 13.5-day
fetus, (E) The ventricular cell layer of the cerebral vesicles
(cv), the diencephalon (di) and the neuroblasts of the
thalamic nuclei (arrowhead) of a 14.5-day fetus, (F) The
neural retina (nr), the conjunctival epithelium (cj) and the
cornea (cr) of the developing eye in a 14.5-day embryo.
The pigment retina (pr) and the lens (In) show no
hybridization. The mesenchyme of the eyelids expressed a
low level of transcripts. (G) Two longitudinal bands (cut in
cross section) of neuroepithelial cells in the basal plate of
the upper rhombencephalon of a 14.5-day fetus; a strong
hybridization was seen in the mesenchyme of the
prospective occipital bone (ob). (H) The ventricular cell
layer (arrowheads) on the basal side of the cervical spinal
cord of a 14.5-day fetus, the cervical vertebral column (vc)
showed an intense hybridization to the probe, (I) The
epithelium of the otocyst (ov) with a concentration of the
hybridization at the apical cytoplasm, and the surrounding
mesenchymal cells of a 10.5-day embryo. (J) The periotic
mesenchyme (po), the differentiating cochlear epithelium
(arrow) of the inner ear and the investing cartilage (oc) of
a 14.5-day fetus, ba, branchial arch; da, dorsal aorta; ly,
laryngeal cartilage; pm, paraxial mesenchyme; se, surface
ectoderm; rp, hypophyseal pouch; rb, ribs. Bar 100/an.
embryogenesis (data not shown) transcripts being
restricted to the neighbouring meninges (Fig. 41). No
significant signal was seen in the brain when sections
were hybridized with sense ad (II) collagen mRNA
probes (Fig. 6A,B), confirming the specificity of hy-
bridization and excludes the possibility of non-specific
sticking of the RNA probes to non-chondrogenic sites.
Discussion
Type II collagen is a major extracellular component of
cartilage and is actively synthesized by chondrocytes
during cartilage formation (von der Mark, 1980).
However, several recent studies have demonstrated
that the gene encoding this collagen is expressed early
in the pre-chondrogenic limb mesenchyme well in
advance of overt cartilage differentiation (Kravis and
Upholt, 1985; Kosher et al. 1986) and the formation of
mesenchymal condensation results in an elevated
expression of the type II collagen transcript (Swalla et
al. 1988). Similar results were obtained from the
present in situ hybridization study in the mouse
embryo. Detectable levels of ad(II) collagen mRNA
were observed early in development in (1) the cranial
paraxial mesenchyme, destined for the formation of the
chondrocranium, (2) the sclerotome, which later forms
the vertebrae, (3) the mesenchymal primordia of the
hyoid and laryngeal cartilage, (4) the thoracic mesen-
chyme for the ribs and (5) the prechondrogenic limb
bud mesenchyme. The early expression of ad(II)
collagen transcripts in the prechondrogenic mesen-
chyme may therefore be interpreted as activity related
to the establishment of the extracellular microenviron-
ment for inducing chondrocyte differentiation.
Recent immunohistochemical studies in avian em-
bryos have revealed that type II collagen is found not
only in the prechondrogenic mesenchyme but also at
the epithelial-mesenchymal interface at prospective
sites of cartilage formation (Kosher and Solursh, 1989;
Thorogood, 1988). Our in situ hybridization studies and
more recent immunohistochemical studies by Wood et
al. 1991 show that the type II collagen gene is similarly
expressed in prechondrogenic and non-chondrogenic
tissues in the developing mouse. Type II collagen is
found on the basal surface of embryonic epithelia such
as the neural tube, the optic and auditory vesicles in the
craniofacial region of the embryo and the notochord.
Fig. 6. In situ hybridization of coronal
sections of a 14.5-day fetus with antisense and
sense pELlll RNA probes. (A) Positive
hybridization of antisense pELlll RNA
transcripts to the neuroepithelium of the
mesencephalon (mt). (B) Absence of signal in
the neuroepithelium with sense pELlll RNA
transcripts. Bar=100/an.
950 K. S. E. Cheah and others
The distribution of type II collagen at these sites
matches closely with the pattern of chondrocranium
development (Thorogood, 1988; Wood et al. 1991).
Taken together, these observations are consistent with
the hypothesis that type II collagen is involved in the
specification of both the temporal and spatial pattern of
chondrogenesis during the development of the skull.
The mouse auditory vesicle (otocyst) in particular has
been shown to be capable of inducing chondrogenesis in
the otic capsule at about 11-13 days p. c. but not earlier
(Van de Water and Ruben, 1974; McPhee and Van de
Water, 1986). This ability to induce chondrogenesis
may be correlated with an increase in the synthesis of
glycosaminoglycans, which like type II collagen are
major matrix components of cartilage. However, type
II collagen is expressed in the otic vesicle as early as 9.5
days (this study and Wood et al. 1991), which may serve
a function related to more than a simple promotion of
chondrocyte differentiation at the time of otic capsule
formation.
In the trunk region, type II collagen is- found
abundantly in the notochord and the sclerotomal
mesenchyme. The appearance of type II collagen
mRNA in this tissue therefore heralds the inductive
influence of the notochord and the concomitant
chondrogenic activity of the somitic mesoderm (Lash,
1968; Cohen and Hay, 1971; Kosher and Lash, 1975).
Our DNA sequence data indicate that there is a high
degree of interspecies homology of the ad(II) collagen
gene in vertebrates. This sequence homology, together
with the conservation of the expression of type II
collagen in the notochord of the sturgeon (Miller and
Mathews, 1974), lamprey (Eikenberry et al. 1984;
Sheren et al. 1986), Xenopus (Ramirez, personal
communication) as well as in the bird and the mouse,
imply that this matrix molecule serves a basic and
common developmental role such as the determination
of the sites of chondrogenesis and the maintenance of
tissue architecture (Trelstad and Birk, 1984; Hay,
1984).
The present in situ hybridization study suggests that
there is active expression of type II collagen mRNA in
the early neuroepithelia of the brain, the eye, the spinal
cord, in the notochord and the otic vesicle of the mouse
embryos at about the stage of type II collagen
deposition in the basal aspect of the embryonic
epithelia. This, therefore, strongly suggests an epi-
thelial origin of the newly synthesized type II collagen,
although contribution by the mesenchyme could not be
ruled out because arl(II) collagen transcripts are also
expressed in the adjacent paraxial mesenchyme and the
peri-otic mesenchyme.
The functional significance of expression of type II
collagen in other non-chondrogenic tissues is unclear.
In addition to the prechondrogenic primordia and the
embryonic epithelia associated with sites of chondro-
genesis, type II collagen has also been detected in other
embryonic tissues apparently unrelated to cartilage
development. In both the chick and the mouse (Kosher
and Solursh, 1989; Wood et al. 1991), type II collagen is
found in the basement membrane of epithelia or tissues
such as the dorsal and lateral surface ectoderm, the
lateral and ventral gut endoderm, the mesonephric
duct, the splanchnic mesoderm and the interface
between the epimyocardium and the endocardium.
With the exception of the gut, the splanchnic meso-
derm, the pharyngeal endoderm and the mesonephric
duct, the present study shows that, in the mouse, type II
collagen mRNA was detected in similar tissues, e.g.
heart and the surface ectoderm. The timing of
expression of ad(II) collagen mRNA in non-chondro-
genic tissues in general paralleled the deposition of the
protein in the extracellular matrix in avians and the
mouse (Thorogood et al. 1986; Fitch et al. 1988; Kosher
and Solursh, 1989; Wood et al. 1991) indicating control
of type II collagen gene expression during these stages
of development at the level of transcription rather than
at translation.
Of particular significance is the localization of o-l(II)
collagen mRNA in the proliferative ventricular cells of
the embryonic brain at 9.5 days and its subsequent
localization to restricted areas in the rhombencephalic
basal plate and the ventricular cells of the cervical spinal
cord. Here, type II collagen may serve to maintain the
organization of the neuroepithelium during active
neurogenesis and neuroblast migration either by acting
as an adhesive molecule between epithelial cells or by
contributing to the basement membrane.
Type II collagen mRNA was also detected in the
neural retina of the eye. This could be related to the
appearance of type II collagen in the internal limiting
membrane and the vitreous humor and may have some
role in guiding the axonal processes of the retinal
ganglion cells as they traverse the retinal surface and
converge to form the optic nerve bundle. The localiz-
ation of type II collagen transcripts in the basal plate of
the rhombencephalon and the basal ventricular layer of
the spinal cord is particularly interesting. This region
also expresses high levels of alkaline phosphatase
between 10.5 and 15.5 days during which time the
arl(II) collagen gene is also transcribed. This part of the
neural tube has been identified as the site of active
production and migration of the motor neuroblasts of
the cranial nerves and the spinal nerves (Kwong and
Tarn, 1984; Tarn and Kwong, 1987). The biological role
of alkaline phosphatase, a membrane-bound enzyme, is
unclear, but it has been proposed that it may participate
in processes such as the mineralization of bone and
cartilage, in Pi-transport, and in the regulation of cell
division and signal transduction (Wuthier and Register,
1985). The significance of co-expression of alkaline
phosphatase and type II collagen in this region is
unknown. In addition to a mechanical support role,
type II collagen may promote, in concert with other
molecules, the migration of the differentiating neuro-
blasts. The early onset and transience of expression,
between 9.5 and 15.5 days, in the neuroepithelium is
consistent with a stage-specific role in neural ontogeny.
The early expression of the alQI) collagen gene in the
neuroepithelium at 9.5 days is particularly interesting
because this coincides with the period of extensive
morphogenesis of the neural tube. Further studies are
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in progress to investigate the early expression of the
o'l(II) collagen in developing neural tissue.
Type II collagen gene transcripts were also found in
supporting/interstitial tissues such as the epimyocar-
dium, the surface ectoderm before full thickness of the
epidermis is formed, the tail tendon and the extra-
embryonic membrane (amnion and yolk sac). It is not
possible from the detection of mRNA alone to predict
the final extracellular destination of the protein
product. The immuno-localization of type II collagen to
the basement membrane of the neural tube and other
embryonic organs (Wood et al. 1991) indicates that,
after synthesis, the protein is secreted and transported
to sites near to the expressing cells. Expression of al(II)
collagen mRNA in the mouse epimyocardium would be
consistent with a final accumulation of the protein at the
interface of the epimyocardium and the endocardium
(Kosher and Solursh, 1989; Wood et al. 1991).
It is of interest that the mRNAs for type I and type II
collagen were expressed together in developing mouse
calvarial bones. The in situ hybridization results
confirm previous studies using RNAase protection
assays (Lovell-Badge et al. 1987). Intramembraneous
bone, unlike endochondral bone, does not go through a
cartilage phase in development and have been classi-
cally thought to synthesize only type I collagen (Jackson
and Randall, 1956; Glimcher, 1976). Our results and
recent findings in the chick (MacDonald and Tuan,
1989) show that this hypothesis is no longer valid and
that type I and type II collagen are co-transcribed in the
formation of calvaria.
The expression of the ad (II) collagen gene in non-
chondrogenic tissue is intriguing and points to a role
apart from chondrogenesis. However, there is the
possibility that the gene product of the o-l(II) collagen
gene expressed in non-chondrogenic tissues is not or
only partly incorporated into the type II collagen
molecules. Type XI collagen, a fibril-forming collagen,
is a quantitatively minor collagen component of hyaline
cartilage and consists of molecules composed of a
heterotrimer of three different polypeptide subunits,
ol(XI), o2(XI), and o3(XI). The o3(XI) chain is
generally thought to be the product of the 0-1(11)
collagen gene whereas the arl(XI) and o2(XI) chains
are distinct gene products (Eyre and Wu, 1987;
Burgeson and Hollister, 1979; Vuorio and DeCrom-
brugghe, 1990). Recent studies have shown that
expression of type XI collagen is not confined to
cartilage (Bernard et al. 1988; Niyibizi and Eyre, 1989;
Yoshioka and Ramirez, 1990) and the mRNAs for the
three a chains of type XI collagen are not always co-
expressed in every tissue (Cheah and Lui, unpublished
results). In the immunohistochemical studies in the
chick and quail (Thorogood et al. 1986; Kosher and
Solursh, 1989) and mouse (Wood et al. 1991), type II
collagen antibodies were used but the possibility of
recognizing a common epitope conferred on types II
and XI collagen by the ol(II)/a3(XI) chains needs to
be excluded. The al(II) collagen mRNAs detected in
non-chondrogenic tissues may therefore represent
either type II or type XI collagen or a mixture of both.
The function of type XI collagen is not fully under-
stood. Recent reports indicate that fibrils in cartilage
contain mixtures of types II, IX and XI collagen
(Mendler et al. 1989). The presence of type V and I
collagens in the collagen fibrils of non-cartilage tissues
is thought to be important in regulating the diameter of
these fibrils in the matrix (Eyre and Wu, 1987; Birk et
al. 1988). Co-expression of types II and XI collagen may
reflect a similar role of type XI collagen in cartilage.
The co-expression of al(II)/a3(XI) and a-l(I) collagen
mRNAs in the developing mouse heart, skin, tendon
and calvaria may reflect such a role. In situ hybridiz-
ation and immunohistochemical studies on the develop-
mental pattern of expression of al(XI) and a2(XI)
collagen should help resolve these possibilities.
Although the developmental role of transient type II
collagen expression in tissue other than cartilage still
remains to be defined, it is interesting that, in many
types of inherited human chondrodysplasias, an associ-
ation of congenital heart defects, abnormalities in
hippocampal formation and skull abnormalities has
been reported (Wynne-Davies et al. 1985; Knisely and
Ambler, 1988). The transient expression of type II
collagen in the developing mouse heart and brain may
therefore have some relevance to the non-skeletal
defects found in human skeletal dysplasias. Exper-
iments aimed at studying the phenotypic effects of
interfering with a-l(II) collagen gene expression should
yield a better insight into the full function of type II
collagen during development.
This work was supported by the Arthritis and Rheumatism
Council, UK and a Hong Kong University Strategic Research
grant. We are indebted to Dr Dave Wilkinson and Dr Peter
Koopman for invaluable guidance and assistance with in situ
hybridization techniques. We also thank Dr Peter Little for
the generous gift of the mouse cosmid library, Dr Mee Len
Chye for assistance in generating ExoLU deletions for DNA
sequencing, Professor Peter Thorogood for communicating
type II collagen immunohistochemical data on the mouse
prior to publication and Dr Robin Lovell-Badge, Dr Wai Sum
O and Professor Peter Rowe for helpful discussion.
References
ADAMSON, E. D. (1982). The effect of collagen on cell division,
cellular differentiation and embryonic development. In Collagen
in Health & Disease (ed. J. B. Weiss and M. W. Jayson), pp.
218-243. Edinburgh: Churchill Livingstone.
BERNARD, M ^ YOSHIOKA, H., .RODRIGUEZ, E., VAN DER REST, M.,
KIMURA, T., NINOMIYA, Y., OLSEN, B. R. AND RAMIREZ, F.
(1988). Cloning and sequencing of proal(XI) collagen cDNA
demonstrates that type XI belongs to the fibrillar class of
collagens and reveals that expression of the gene is not
restricted to cartilagenous tissues. J. biol. Chem. 263,
17159-17166.
BIRK, D. E., FITCH, J. M., BABIARZ, J. P. AND LINSENMEYER, T. F.
(1988). Collagen type I and type V are present in the same fibril
in the avian corneal stroma. J. Cell Biol. 106, 999-1008.
BURGESON, R. E. AND HOLUSTER, D. W. (1979). Collagen
heterogeneity in human cartilage: identification of several new
collagen chains. Biochem. biophys. Res. Commun. 87,
1124-1131.
CHEAH, K. S. E., A U , P. K. C , LAU, E. T., LITTLE, P. F. R. AND
STUBBS, L. (1991). The mouse Col2a-1 gene is highly conserved
952 K. S. E. Cheah and others
and is linked to lnt-1 on chromosome 15. Mammalian Genome
(in press).
CHEAH, K. S. E., STOKER, N. G., GRIFFIN, J. R., GROSVELD, F. G.
AND SOLOMON, E. (1985). Identification and characterisation of
the human type II collagen gene (COL2A1). Proc. natn. Acad.
Sci. U.S.A. 82, 2555-2559.
COHEN, A. M. AND HAY, E. D. (1971). Secretion of collagen by
embryonic neural epithelium at the time of spinal cord-somite
interaction. Devi Biol. 26, 578-605.
CROSS, S. H. AND LITTLE, P. F. R. (1986). A cosmid vector for
systematic chromosome walking. Gene 49, 9-22.
DEVEREUX, J., HAEBERU, P. AND SMITHIES, O. (1984). A
comprehensive set of sequence analysis programs for the VAX.
Nucl. Acids Res. 12, 387-395.
DION, A. S. AND MYERS, J. C. (1987). COOH-terminal
propeptides of the major human procollagens. Structural
functional and genetic comparisons. /. molec. Biol. 193, 127-143.
EIKENBERRY, E. F., CHILDS, B., SHEREN, S. B., PARRY, D. A.,
CRAIG, A. S. AND BRODSKY, B. (1984). Crystalline fibril structure
of type II collagen in lamprey notochord sheath. /. molec. Biol.
176, 216-277.
EYRE, D. AND WU, J. J. (1987). Type XI or Io2a3a collagen in
Structure and Function of Collagen types, (ed. R Mayne and R.
E. Burgeson) pp. 261-281. Orlando: Academic Press.
FITCH, J. M., MENTZER, A., MAYNE, R. AND LJNSENMAYER, T. F.
(1988). Acquisition of type IX collagen by the developing avian
primary corneal stroma and vitreous. Devi Biol. 128, 396—405.
FITCH, J. M., MENTZER, A., MAYNE, R. AND LINSENMAYER, T. F.
(1989). Independent deposition of collagen types II and IX at
epithelial-mesenchymal interfaces. Development 105, 85-95.
GUMCHER, M. (1976). Composition, structure and organisation of
bone and other mineralised tissues and the mechanism of
calcification. In Handbook of Physiology, vol. Ill pp. 25-116.
Baltimore: Williams and Wilkins.
HARBERS, K., KUEHN, M., DELJUS, H. AND JAENISCH, R. (1984).
Insertion of retrovirus into the first intron of arl(I) collagen gene
leads to embryonic lethal mutation in mice. Proc. natn. Acad.
Sci. U.S.A. 81, 1504-1508.
HAY, E. D. (1984). Cell-matrix interaction in the embryo: cell
shape, cell surface, cell skeletons and their role in differentiation.
In The Role of Extracellular Matrix in Development (ed. R. L.
Trelstad) pp. 1-31. New York: Alan R. Liss.
HAYASHI, M., NINOMIYA, Y., HAYASHI, K., LINSENMAYEK, T. F.,
OLSEN, B. R. AND TRELSTAD, R. L. (1988). Secretion of
collagen types I and II by epithelial and endothelial cells in the
developing chick corneal demonstrated by in situ hybridisation
and immunohistochemistry. Development 103, 27-36.
HENIKOFF, S. (1987). Unidirectional digestion with exonuclease III
in DNA sequence analysis. Methods. Enzymol. 155, 156-165.
JACKSON, S. F. AND RANDALL, J. (1956). Fibrogenesis and the
formation of matrix in developing bone. In CIBA Foundation
Symposium of Bone Structure and Metabolism, (ed. G.
Wolstenholme and H. O'Connor, pp. 47-62. Boston: Little, Brown.
KNISELY, A. S. AND AMBLER, M. W. (1988). Temporal-lobe
abnormalities in thanatophoric dysplasia. Pediatr. Neurosci 14,
169-176.
KOHNO, K., SULLIVAN, M. AND YAMADA, Y. (1985). Structure of
the promoter of the rat type II procollagen gene. J. biol. Chem.
260, 4441-4447.
KOSHER, R. A., KULYK, W. M. AND GAY, S. W. (1986). Collagen
gene expression during limb cartilage differentiation. J. Cell
Biol. 102, 1151-1156.
KOSHER, R. A. AND LASH, J. W. (1975). Notochordal stimulation
of in vitro somite chondrogenesis before and after enzymatic
removal of perinotochordal materials. Devi Biol. 42, 362-378.
KOSHER, R. A. AND SOLURSH, M. (1989). Widespread distribution
of type II collagen during embryonic chick development. Devi
Biol. 131, 558-566.
KRAVIS, D. AND UPHOLT, W. B. (1985). Quantitation of type II
procollagen raRNA levels during chick limb cartilage
differentiation. Devi Biol. 108, 164-172.
KWONG, W. H. AND TAM, P. P. L. (1984). The pattern of alkaline
phosphatase activity in the developing mouse spinal cord. J.
Embryo!, exp. Morph. 82, 241-251.
LASH, J. W. (1968). Semitic mesenchyme and its response to
cartilage induction. In Epithelial-mesenchymal Interactions (ed.
R. F. Fleischmijer and R. E. Billingham), pp. 165-172.
Baltimore: Williams and Wilkins.
LINSENMAYER, T. F. AND LITTLE, C. D. (1978). Embryonic neural
retina collagen: In vitro synthesis of high molecular weight forms
of type II plus a new genetic type. Proc. natn. Acad. Sci.
U.S.A. 75, 3235-3239.
LINSENMAYER, T. F., SMITH, G. N. AND HAY, E. D. (1977).
Synthesis of two collagen types by embryonic chick corneal
epithelium in vitro. Proc. natn. Acad. Sci. U.S.A. 74, 39-43.
LOVELL-BADGE, R. H. (1987). Introduction of DNA into
embryonic stem cells. In Teratocarcinomas and Embryonic Stem
Cells - a Practical Approach, pp. 153-182 (ed. E. J. Robertson)
Oxford: IRL Press.
LOVELL-BADGE, R. H., BYGRAVE, A. E., BRADLEY, A., ROBERTSON,
E., TILLEY, R. AND CHEAH, K. S. E. (1987). Tissue specific
expression of the human type II collagen gene in mice. Proc.
natn. Acad. Sci. U.S.A. 84, 2803-2807.
MALLEIN-GERIN, F. (1990). Subepithelial type II collagen
deposition during embryonic chick limb development. Roux's
Arch, devl Biol. 198, 363-369.
MCDONALD, S. A. AND TUAN, R. S. (1989). Expression of collagen
type transcripts in chick embryonic bone detected by in situ
cDNA-mRNA hybridization. Devi Biol. 133, 221-234.
MCPHEE, J. R. AND VAN DE WATER, T. R. (1986). Epithelial-
mesenchymal interactions guiding otic capsule formation: The
role of the otocyst. J. Embryol. exp. Morph. 97, 1-24.
MELTON, D. A., KRIEG, P. A., REBAGUATI, M. R., MANIATIS, T.,
ZINN, K. AND GREEN, M. R. (1984). Efficient in vitro synthesis
of biologically active RNA and RNA hybridization probes from
plasmids containing a bacteriophage SP6 promoter. Nucl. Acids
Res. 12, 7035-7050.
MENDLER, M., EICH-BENDER, S. G., VAUGHIN, L., WINTERHALTER,
K. H., AND BRUCKNER, P. (1989). Cartilage contains mixed
fibrils of collagen types II, IX and XI, /. Cell Biol. 108, 191-197.
MILLER, E. J. AND GAY, S. (1987). The collagens: an overview and
update. Methods Enzymol. 144, 1-39.
MILLER, E. J. AND MATHEWS, M. B. (1974). Characterization of
notochord collagen as a cartilage-type collagen. Biochem.
biophys. Res. Commun. 60, 424-430.
NEWSOME, D. A., LINSENMAYER, T. F. AND TRELSTAD, R. L.
(1976). Vitreous body collagen. Evidence for a dual origin from
the neural retina and hyalocytes. J. Cell Biol. 71, 59-67.
NIYIBIZI, C. AND EYRE, D. R. (1989). Identification of the cartilage
a-l(XI) chain in type V collagen from bovine bone. FEBS Lett.
242, 314-318.
NUNEZ, A. M., KOHNO, K., MARTIN, G. R. AND YAMADA, Y.
(1986). Promoter region of the human pro-arl(n)-collagen gene.
Gene 44, 11-16.
OETTINGER, H. F., THAL, G., SASSE, J., HOLTZER, H. AND
PACIFICI, M. (1985). Immunological analysis of chick notochord
and cartilage matrix development with antisera to cartilage
matrix macromolecules. Devi Biol. 109, 63-71.
RAMIREZ, F., BERNARD, M., CHU, M.-L., DICKSON, L., SANGIORGI,
F., WEIL, D., DE WET, W., JUNIEN, C. AND SOBEL, M. (1985).
Isolation and characterisation of the human fibrillar collagen
genes. N.Y. Acad. Sci. 460, 117-129.
REDDI, A. H. (1984). Extracellular matrix and development. In
Extracellular Matrix Biochemistry (ed. K. A. Piez and A. H.
Reddi), pp. 375-412. New York: Elsevier Science.
RUGH, R. (1968). The Mouse, its Reproduction and Development.
Minneapolis: Burgess Pub. Co.
SANGER, F., NICKLEN, S. AND COULSEN, A. R. (1977). DNA
sequencing with chain-terminating inhibitors. Proc. natn. Acad.
Sci. U.S.A. 74, 5463-5467.
SCHNIEKE, A., HARBERS, K., DEUUS, H. AND JAENISCH, R. (1983).
Embryonic lethal mutation in mice induced by retrovirus
insertion in the a-l(I) collagen gene. Nature, Lond. 304,
315-320.
SHEREN, S. B., EIKENBERRY, E. F., BROCK, D. L., VAN DER REST,
M., DOERING, T., KELLEY, J., HARDT, T. AND BRODSKY, B.
(1986). Type II collagen of lamprey. Comp. Biochem. Physiol.
85B, 5-14.
Type II collagen gene expression 953
SMITH, G. N., LINSENMAYER, T. F. AND NEWSOME, D. A. (1976).
Synthesis of type II collagen in vitro by embryonic chick neural
retina tissue. Proc. natn. Acad. Sci. U.S.A. 73, 4420-4423.
SWALLA, B. J., UPHOLT, W. B. AND SOLURSH, M. (1988). Analysis
of type II collagen RNA localization in chick wing buds by in
situ hybridization. Devi Biol. 125, 51-58.
TAM, P. P. L. AND KWONG, W. H. (1987). A study on the pattern
of alkaline phosphatase activity correlated with observations on
silver-impregnated structures in the developing mouse brain. J.
Anat. 150, 169-180.
THOROGOOD, P. (1988). The developmental specification of the
vertebrate skull. Development 103, (Suppl.), 141-153.
THOROGOOD, P., BEE, J. AND VON DER MARK, K. (1986). Transient
expression of cartilage type IT at epitheliomesenchymal
interfaces during morphogenesis of the cartilagenous
neurocranium. Devi Biol. 116, 497-509.
TRELSTAD, R. L. AND BIRK, D. E. (1984). Collagen fibril assembly
at the surface of polarised cells. In The Role of Extracellular
Matrix in Development (ed. R. L. Trelstad) pp. 513-543. New
York: Alan R. Liss.
TRELSTAD, R. L. AND KANG, A. H. (1974). Collagen heterogeneity
in the avian eye: Lens, vitreous body, cornea, and sclera. Expl
Eye Res. 18, 395-406.
VAN DE WATER, T. R. AND RUBEN, R. J. (1974). Growth of the
inner ear in organ culture. Ann Owl. Rhinol. Lar. 83, Suppl.
14, 1-21.
VON DER MARK, H., VON DER MARK, K. AND GAY, S. (1976). Study
of differential collagen synthesis during development of the
chick embryo by immunofluorescence. I. Preparation of collagen
type I and type II specific antibodies and their applications to
early stages of the chick embryo. Devi Biol. 48, 237-249.
VON DER MARK, K., VON DER MARK, H., TIMPL, R. AND TRELSTAD,
R. L. (1977). Immunofluorescent localization of collagen types I,
II and III in the embryonic chick eye. Devi Biol. 59, 75-85.
VON DER MARK, K. (1980). Immunological studies and collagen
type transition in chondrogenesis. Curr. Topic, devl Biol. 14,
199-225.
VON DER MARK, K. AND VON DER MARK, H. (1977). Immunological
and biochemical studies of collagen type transition during in
vitro chondrogenesis of chick limb mesodermal cell. J. Cell Biol.
73, 736-747.
VUORJO, E. AND DE CROMBRUGGHE, B. (1990). The family of
collagen genes. Ann Rev. Biochem. 59, 837-872.
WILKINSON, D. G., BAILES, J. A. AND MCMAHON, A. P. (1987).
Expression of the proto-oncogene int-1 is restricted to specific
neural cells in the developing mouse embryo. Cell 50, 79-88.
WOOD, A., ASHURST, D., CORBETT, A. AND THOROGOOD, P. (1991).
The transient expression of type II collagen at tissue interfaces
during mammalian craniofacial development. Development 111,
955-968.
WUTHIER, R. E. AND REGISTER, T. C. (1985). Role of alkaline
phosphatase, a polyfunctional enzyme in mineralising tissues. In
The Chemistry and Biology of Mineralised Tissue (ed. W. T.
Butler) pp. 113-124 Birmingham: Ebsco Media.
WYNNE-DAVIES, R., HALL, C. M. AND APLEY, A. G. (1985). Atlas
of Skeletal Dysplasias. Edinburgh: Churchill Livingstone.
YOSHIOKA, H. AND RAMIREZ, F. (1990). Pro-o-l(XI) collagen,
structure of the amino-terminal propeptide and expression of the
gene in tumor cell lines. / . biol. Chem 265, 6423-6426.
(Accepted 5 December 1990)
